Orthotopic patient-derived xenografts of paediatric solid tumours

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · see citing works

ChromHMM: automating chromatin-state discovery and characterization

Ernst, J., & Kellis, M. (2012) · Nature Methods · doi:10.1038/nmeth.1906 · Cited by 2,489 · see citing works

Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients

van de Wetering, M., Francies, H. E., Francis, J. M., Bounova, G., Iorio, F., Pronk, A., van Houdt, W., van Gorp, J., Taylor-Weiner, A., Kester, L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.053 · Cited by 2,408 · see citing works

Organoid models of human and mouse ductal pancreatic cancer

Boj, S. F., Hwang, C.-I., Baker, L. A., Chio, I. I. C., Engle, D. D., Corbo, V., Jager, M., Ponz-Sarvise, M., Tiriac, H., Spector, M. S., et al. (2015) · Cell · doi:10.1016/j.cell.2014.12.021 · Cited by 2,150 · see citing works

Organoid Cultures Derived from Patients with Advanced Prostate Cancer

Gao, D., Vela, I., Sboner, A., Iaquinta, P. J., Karthaus, W. R., Gopalan, A., Dowling, C., Wanjala, J. N., Undvall, E. A., Arora, V. K., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.016 · Cited by 1,559 · see citing works

Bioassay Analysis using R

Ritz, C., & Streibig, J. C. (2005) · Journal of Statistical Software · doi:10.18637/jss.v012.i05 · Cited by 1,456 · see citing works

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

Gao, H., Korn, J. M., Ferretti, S., Monahan, J. E., Wang, Y., Singh, M., Zhang, C., Schnell, C., Yang, G., Zhang, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3954 · Cited by 1,393 · see citing works

Chi-squared and Fisher-Irwin tests of two-by-two tables with small sample recommendations

Campbell, I. (2007) · Statistics in Medicine · doi:10.1002/sim.2832 · Cited by 912 · see citing works

Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma

Chen, X., Bahrami, A., Pappo, A., Easton, J., Dalton, J., Hedlund, E., Ellison, D., Shurtleff, S., Wu, G., Wei, L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.003 · Cited by 752 · see citing works

Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs

Hafner, M., Niepel, M., Chung, M., & Sorger, P. K. (2016) · Nature Methods · doi:10.1038/nmeth.3853 · Cited by 681 · see citing works

Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 Mutations

Tirode, F., Surdez, D., Ma, X., Parker, M. D., Deley, M. L., Bahrami, A., Zhang, Z., Lapouble, E., Grossetête, S., Rusch, M., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0622 · Cited by 569 · see citing works

Declining childhood and adolescent cancer mortality

Smith, M. A., Altekruse, S. F., Adamson, P. C., Reaman, G. H., & Seibel, N. L. (2014) · Cancer · doi:10.1002/cncr.28748 · Cited by 542 · see citing works

A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds

Bruna, A., Rueda, O. M., Greenwood, W., Batra, A. S., Callari, M., Batra, R. N., McNamara, K. L., Sandoval, J. L., Cassidy, J. W., Vidaković, A. T., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.041 · Cited by 432 · see citing works

Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges

Atadja, P. W. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.019 · Cited by 425 · see citing works

Functional Heterogeneity of Genetically Defined Subclones in Acute Myeloid Leukemia

Klco, J. M., Spencer, D. H., Miller, C. A., Griffith, M., Westover, T., O’Laughlin, M. D., Fronick, C. C., Magrini, V. J., Demeter, R., Fulton, R. S., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.031 · Cited by 391 · see citing works

Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors

Do, K. T., Wilsker, D. F., Ji, J. J., Zlott, J., Freshwater, T., Kinders, R. J., Collins, J. M., Chen, A. P., Doroshow, J. H., & Kummar, S. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.4009 · Cited by 322 · see citing works

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

Townsend, E. C., Murakami, M. A., Christodoulou, A., Christie, A. L., Köster, J., DeSouza, T. A., Morgan, E. A., Kallgren, S. P., Liu, H., Wu, S.-C., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.008 · Cited by 295 · see citing works

Targeting Oxidative Stress in Embryonal Rhabdomyosarcoma

Chen, X. '., Stewart, E. A., Shelat, A. A., Qu, C., Bahrami, A., Hatley, M. E., Wu, G., Bradley, C. L., McEvoy, J. D., Pappo, A. S., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.11.002 · Cited by 293 · see citing works

The analysis of 2 × 2 contingency tables—Yet again

Richardson, J. T. E. (2011) · Statistics in Medicine · doi:10.1002/sim.4116 · Cited by 290 · see citing works

Genomic landscape of paediatric adrenocortical tumours

Pinto, E. M., Chen, X. '., Easton, J. B., Finkelstein, D., Liu, Z., Pounds, S. B., Galindo, C. R., Lund, T. C., Mardis, E. R., Wilson, R. K., et al. (2015) · Nature Communications · doi:10.1038/ncomms7302 · Cited by 212 · see citing works

Targeting the DNA Repair Pathway in Ewing Sarcoma

Stewart, E. A., Goshorn, D. R., Bradley, C. L., Griffiths, L. M., Benavente, C. A., Twarog, N. R., Miller, G. M., Caufield, W. V., Freeman, B. B., Bahrami, A., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.028 · Cited by 179 · see citing works

In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma

Ocio, E. M., Vilanova, D., Atadja, P. W., Maiso, P., Crusoé, E. D. Q., Fernández‐Lázaro, D., Garayoa, M., San‐Segundo, L., Hernández‐Iglesias, T., de Álava, E., et al. (2009) · Haematologica · doi:10.3324/haematol.2009.015495 · Cited by 158 · see citing works

Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma

Reece, D. E., Sullivan, D., Lonial, S., Mohrbacher, A., Chatta, G. S., Shustik, C., Burris, H. A., Venkatakrishnan, K., Neuwirth, R. B., Riordan, W., et al. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1283-3 · Cited by 110 · see citing works

Panobinostat Enhances Cytarabine and Daunorubicin Sensitivities in AML Cells through Suppressing the Expression of BRCA1, CHK1, and Rad51

Xie, C., Drenberg, C. D., Edwards, H. J., Caldwell, J. T., Chen, W., Inaba, H., Xu, X., Buck, S. A., Taub, J. W., Baker, S. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079106 · Cited by 94 · see citing works

Pediatric solid tumor genomics and developmental pliancy

Chen, X. '., Pappo, A. S., & Dyer, M. A. (2015) · Oncogene · doi:10.1038/onc.2014.474 · Cited by 84 · see citing works

The public repository of xenografts enables discovery and randomized phase II-like trials in mice

Townsend, E. C., Murakami, M. A., Christodoulou, A., Christie, A. L., Köster, J., DeSouza, T. A., Morgan, E. A., Kallgren, S. P., Liu, H., Wu, S.-C., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.06.008 · Cited by 80 · see citing works

The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities

Stewart, E. A., Federico, S. M., Karlström, Å., Shelat, A. A., Sablauer, A., Pappo, A. S., & Dyer, M. A. (2015) · Developmental Biology · doi:10.1016/j.ydbio.2015.03.001 · Cited by 79 · see citing works

Evaluation of Homogenization Techniques for the Preparation of Mouse Tissue Samples to Support Drug Discovery

Liang, X., Ubhayakar, S., Liederer, B. M., Dean, B., Qin, A., Shahidi-Latham, S. K., & Deng, Y. (2011) · Bioanalysis · doi:10.4155/bio.11.181 · Cited by 47 · see citing works

Preclinical Models Provide Scientific Justification and Translational Relevance for Moving Novel Therapeutics into Clinical Trials for Pediatric Cancer

Langenau, D. M., Sweet-Cordero, A., Wechsler‐Reya, R. J., & Dyer, M. A. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1308 · Cited by 24 · see citing works

Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments

Zarzosa, P., Navarro, N., Giralt, I., Molist, C., Almazán-Moga, A., Vidal, I., Soriano, A., Segura, M. F., Hladun, R., Villanueva, A., et al. (2016) · Clinical & Translational Oncology · doi:10.1007/s12094-016-1557-2 · Cited by 23 · see citing works

Tumor targeting via EPR: Strategies to enhance patient responses

Golombek, S. K., May, J.-N., Theek, B., Appold, L., Drude, N., Kiessling, F., & Lammers, T. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.007 · Cited by 1,262 · see citing works

Rhabdomyosarcoma

Skapek, S. X., Ferrari, A., Gupta, A. A., Lupo, P. J., Butler, E. B., SHIPLEY, J. M., Barr, F. G., & Hawkins, D. S. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0051-2 · Cited by 909 · see citing works

Ewing sarcoma

Grünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0003-x · Cited by 873 · see citing works

A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors

Slyper, M., Porter, C. B. M., Ashenberg, O., Waldman, J., Drokhlyansky, E., Wakiro, I., Smillie, C. S., Smith-Rosario, G., Wu, J., Dionne, D. A., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0844-1 · Cited by 739 · see citing works

Osteosarcoma

Beird, H. C., Bielack, S. S., Flanagan, A. M., Gill, J., Heymann, D., Janeway, K. A., Livingston, J. A., Roberts, R. D., Strauss, S. J., & Gorlick, R. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00409-y · Cited by 660 · see citing works

Genome-Informed Targeted Therapy for Osteosarcoma

Sayles, L. C., Breese, M. R., Koehne, A. L., Leung, S. G., Lee, A. G., Liu, H.-Y., Spillinger, A., Shah, A. T., Tanasa, B., Straessler, K., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1152 · Cited by 452 · see citing works

Sarcoma treatment in the era of molecular medicine

Grünewald, T. G., Alonso, M., Avnet, S., Banito, A., Burdach, S., Cidre‐Aranaz, F., Di Pompo, G., Distel, M., Dorado‐Garcia, H., Garcia‐Castro, J., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911131 · Cited by 319 · see citing works

The Circular RNA circPRKCI Promotes Tumor Growth in Lung Adenocarcinoma

Qiu, M., Xia, W., Chen, R., Wang, S., Xu, Y., Ma, Z., Xu, W., Zhang, E., Wang, J., Tian, F., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2808 · Cited by 285 · see citing works

St. Jude Cloud: A Pediatric Cancer Genomic Data-Sharing Ecosystem

McLeod, C., Gout, A. M., Zhou, X., Thrasher, A., Rahbarinia, D., Brady, S. W., Macias, M., Birch, K., Finkelstein, D., Sunny, J., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1230 · Cited by 262 · see citing works

Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish

Yan, C., Brunson, D. C., Tang, Q., Do, D., Iftimia, N. A., Moore, J. C., Hayes, M. N., Welker, A. M., Garcia, E. G., Dubash, T. D., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.004 · Cited by 242 · see citing works

Genomic and phenotypic characterization of a broad panel of patient-derived xenografts reflects the diversity of glioblastoma

Vaubel, R. A., Tian, S., Remonde, D., Schroeder, M. A., Mladek, A. C., Kitange, G. J., Caron, A., Kollmeyer, T. M., Grove, R., Peng, S., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0909 · Cited by 227 · see citing works

Genomic evolution of cancer models: perils and opportunities

Ben‐David, U., Beroukhim, R., & Golub, T. R. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0095-3 · Cited by 220 · see citing works

Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design

Rokita, J. L., Rathi, K. S., Cardenas, M., Upton, K. A., Jayaseelan, J. C., Cross, K. L., Pfeil, J., Egolf, L. E., Way, G. P., Farrel, A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.071 · Cited by 178 · see citing works

A biobank of patient-derived pediatric brain tumor models

Brabetz, S., Leary, S. E. S., Gröbner, S. N., Nakamoto, M. W., Seker‐Cin, H., Girard, E. J., Cole, B., Strand, A. D., Bloom, K., Hovestadt, V., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0207-3 · Cited by 173 · see citing works

XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence data

Kluin, R. J. C., Kemper, K., Kuilman, T., de Ruiter, J. R., Iyer, V., Forment, J. V., Cornelissen‐Steijger, P., de Rink, I., ter Brugge, P., Song, J., et al. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2353-5 · Cited by 159 · see citing works

Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours

Jones, D., Banito, A., Grünewald, T. G. P., Haber, M., Jäger, N., Kool, M., Milde, T., Molenaar, J. J., Nabbi, A., Pugh, T. J., et al. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0169-x · Cited by 155 · see citing works

Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses

Stewart, E., McEvoy, J., Wang, H., Chen, X., Honnell, V., Ocarz, M., Gordon, B., Dapper, J., Blankenship, K., Yang, Y., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.07.012 · Cited by 153 · see citing works

Drug repurposing screening and mechanism analysis based on human colorectal cancer organoids

Mao, Y., Wang, W., Yang, J., Zhou, X., Lu, Y., Gao, J., Wang, X., Wen, L., Fu, W., & Tang, F. (2023) · Protein & Cell · doi:10.1093/procel/pwad038 · Cited by 151 · see citing works

Inhibiting Wee1 and ATR kinases produces tumor-selective synthetic lethality and suppresses metastasis

Bukhari, A. B., Lewis, C. W., Pearce, J. J., Luong, D., Chan, G. K. T., & Gamper, A. M. (2019) · Journal of Clinical Investigation · doi:10.1172/jci122622 · Cited by 138 · see citing works

MYCN amplification and ATRX mutations are incompatible in neuroblastoma

Zeineldin, M., Federico, S. M., Chen, X. '., Fan, Y., Xu, B., Stewart, E. A., Zhou, X., Jeon, J., Griffiths, L. M., Nguyen, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14682-6 · Cited by 128 · see citing works

Research Progress, Challenges, and Breakthroughs of Organoids as Disease Models

Huang, Y., Huang, Z., Tang, Z., Chen, Y., Huang, M., Liu, H., Huang, W., Ye, Q., & Jia, B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.740574 · Cited by 128 · see citing works

Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group

Roberts, R. D., Lizardo, M. M., Reed, D. R., Hingorani, P., Glover, J., Allen‐Rhoades, W., Fan, T., Khanna, C., Sweet‐Cordero, E. A., Cash, T., et al. (2019) · Cancer · doi:10.1002/cncr.32351 · Cited by 127 · see citing works

Molecular mechanisms underpinning sarcomas and implications for current and future therapy

Damerell, V., Pepper, M. S., & Prince, S. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00647-8 · Cited by 114 · see citing works

Retinoblastoma from human stem cell-derived retinal organoids

Norrie, J. L., Nityanandam, A., Lai, K., Chen, X. '., Wilson, M. W., Stewart, E. A., Griffiths, L. M., Jin, H., Wu, G., Orr, B. A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24781-7 · Cited by 110 · see citing works

Patient-derived tumor-like cell clusters for drug testing in cancer therapy

Yin, S., Xi, R., Wu, A., Wang, S., Li, Y., Wang, C., Tang, L., Xia, Y., Yang, D., Li, J., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz1723 · Cited by 104 · see citing works

Improving accessibility of EPR-insensitive tumor phenotypes using EPR-adaptive strategies: Designing a new perspective in nanomedicine delivery

Dhaliwal, A. K., & Zheng, G. (2019) · Theranostics · doi:10.7150/thno.37204 · Cited by 103 · see citing works

Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment

Zhu, Y.-H., Zheng, J.-H., Jia, Q.-Y., Duan, Z., Yao, H., Yang, J., Sun, Y., Jiang, S.-H., Liu, D., & Huo, Y. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00741-1 · Cited by 96 · see citing works

Using PDX for Preclinical Cancer Drug Discovery: The Evolving Field

Williams, J. A. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7030041 · Cited by 94 · see citing works

Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression

Fan, T. M., Roberts, R. D., & Lizardo, M. M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00013 · Cited by 90 · see citing works

Chimeric protein probes for C5a receptors through fusion of the anaphylatoxin C5a core region with a small-molecule antagonist

Zuo, C., Shi, W., Chen, X., Glatz, M., Riedl, B., Flamme, I., Pook, E., Wang, J., Fang, G., Bierer, D. E., et al. (2019) · Science China Chemistry · doi:10.1007/s11426-019-9513-2 · Cited by 83 · see citing works

Sarcoma Spheroids and Organoids—Promising Tools in the Era of Personalized Medicine

Colella, G., Fazioli, F., Gallo, M., Chiara, A. D., Apice, G., Ruosi, C., Cimmino, A., & de Nigris, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020615 · Cited by 82 · see citing works

Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations

Nanni, P., Landuzzi, L., Manara, M. C., Righi, A., Nicoletti, G., Cristalli, C., Pasello, M., Parra, A., Carrabotta, M., Ferracin, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48634-y · Cited by 82 · see citing works

The clonal evolution of metastatic colorectal cancer

Dang, H. X., Krasnick, B. A., White, B. S., Grossman, J. G., Strand, M. S., Zhang, J., Cabanski, C. R., Miller, C. A., Fulton, R. S., Goedegebuure, S. P., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay9691 · Cited by 82 · see citing works

Canine and murine models of osteosarcoma

Beck, J. A., Ren, L., Huang, S., Berger, E. P., Bardales, K., Mannheimer, J., Mazcko, C. N., & LeBlanc, A. K. (2022) · Veterinary Pathology · doi:10.1177/03009858221083038 · Cited by 79 · see citing works

The secret lives of cancer cell lines

Hynds, R. E., Vladimirou, E., & Janes, S. M. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.037366 · Cited by 77 · see citing works

Insights into pediatric rhabdomyosarcoma research: Challenges and goals

Yohe, M. E., Heske, C. M., Stewart, E. A., Adamson, P. C., Ahmed, N. M., Antonescu, C. R., Chen, E. Y., Collins, N. B., Ehrlich, A. R., Galindo, R. L., et al. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.27869 · Cited by 77 · see citing works

Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe

Hettmer, S., Linardic, C. M., Kelsey, A. M., Rudzinski, E. R., Vokuhl, C., Selfe, J., Ruhen, O., Shern, J. F., Khan, J. I., Kovach, A. R., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.05.036 · Cited by 77 · see citing works

Can intracellular drug delivery using hyaluronic acid functionalised pH-sensitive liposomes overcome gemcitabine resistance in pancreatic cancer?

Tang, M., Svirskis, D. M., Leung, E. Y., Kanamala, M., Wang, H., & Wu, Z. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.05.018 · Cited by 75 · see citing works

Targeting Wee1 kinase as a therapeutic approach in Hematological Malignancies

Vakili‐Samiani, S., Jalil, A. T., Abdelbasset, W. K., Yumashev, A. V., Karpisheh, V., Jalali, P., Adibfar, S., Ahmadi, M., Feizi, A. A. H., & Jadidi‐Niaragh, F. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103203 · Cited by 72 · see citing works

The myogenesis program drives clonal selection and drug resistance in rhabdomyosarcoma

Patel, A. G., Chen, X. '., Huang, X., Clay, M. R., Komarova, N. L., Krasin, M. J., Pappo, A. S., Tillman, H. S., Orr, B. A., McEvoy, J. D., et al. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.04.003 · Cited by 72 · see citing works

Strategic development of AZD1775, a Wee1 kinase inhibitor, for cancer therapy

Fu, S., Wang, Y., Keyomarsi, K., & Meric-Bernstein, F. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1511700 · Cited by 71 · see citing works

Drugging the “Undruggable” MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers

Wolpaw, A. J., Bayliss, R. W., Büchel, G., Dang, C. V., Eilers, M., Gustafson, W. C., Hansen, G. M., Jura, N., Knapp, S., Lemmon, M. A., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3108 · Cited by 70 · see citing works

Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM

Peterziel, H., Jamaladdin, N., ElHarouni, D., Gerloff, X. F., Herter, S., Fiesel, P., Berker, Y., Blattner-Johnson, M., Schramm, K., Jones, B. C., et al. (2022) · npj Precision Oncology · doi:10.1038/s41698-022-00335-y · Cited by 69 · see citing works

The design, analysis and application of mouse clinical trials in oncology drug development

Guo, S., Jiang, X., Mao, B., & Li, Q.-X. (2019) · BMC Cancer · doi:10.1186/s12885-019-5907-7 · Cited by 68 · see citing works

Single-cell analysis and functional characterization uncover the stem cell hierarchies and developmental origins of rhabdomyosarcoma

Wei, Y., Qin, Q., Yan, C., Hayes, M. N., Garcia, S. P., Xi, H., Do, D., Jin, A., Eng, T. C. Y., McCarthy, K. M., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00414-w · Cited by 66 · see citing works

Hit Triage and Validation in Phenotypic Screening: Considerations and Strategies

Vincent, F., Loria, P. M., Weston, A. D., Steppan, C. M., Doyonnas, R., Wang, Y., Rockwell, K. L., & Peakman, M. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.08.009 · Cited by 58 · see citing works

The Landscape of Pediatric Precision Oncology: Program Design, Actionable Alterations, and Clinical Trial Development

Langenberg, K. P. S., Looze, E. J., & Molenaar, J. J. (2021) · Cancers · doi:10.3390/cancers13174324 · Cited by 57 · see citing works

ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity

Zucchini, C., Manara, M. C., Cristalli, C., Carrabotta, M., Greco, S., Pinca, R. S., Ferrari, C., Landuzzi, L., Pasello, M., Lollini, P., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1506-3 · Cited by 57 · see citing works

Recent advances in microfluidic technology and applications for anti-cancer drug screening

Shi, Y., Cai, Y., Cao, Y., Hong, Z., & Chai, Y. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.116118 · Cited by 57 · see citing works

Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes

Meister, M. T., Koerkamp, M. J. A. G., de Souza, T. M., Breunis, W. B., Frazer‐Mendelewska, E., Brok, M. O., DeMartino, J., Manders, F., Calandrini, C., Kerstens, H. H. D., et al. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202216001 · Cited by 55 · see citing works

High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer

Mayoh, C., Mao, J., Xie, J., Tax, G., Chow, S., Cadiz, R., Pazaky, K., Barahona, P., Ajuyah, P., Trebilcock, P., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-3702 · Cited by 55 · see citing works

Animal Models in Microbeam Radiation Therapy: A Scoping Review

Fernández-Palomo, C., Fazzari, J., Trappetti, V., Smyth, L. M. L., Janka, H., Laissue, J. A., & Djonov, V. (2020) · Cancers · doi:10.3390/cancers12030527 · Cited by 51 · see citing works

An overview of neuroblastoma cell lineage phenotypes and in vitro models

Cogo, S. C., do Nascimento, T. G. F. D. C., Pinhatti, F. D. A. B., de França, N., Rodrigues, B. S., Cavalli, L. R., & Elífio-Esposito, S. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220949237 · Cited by 50 · see citing works

Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy

Kamili, A., Gifford, A. J., Li, N., Mayoh, C., Chow, S., Failes, T. W., Eden, G. L., Cadiz, R., Xie, J., Lukeis, R. E., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0682-4 · Cited by 50 · see citing works

Single cell transcriptomic profiling identifies tumor-acquired and therapy-resistant cell states in pediatric rhabdomyosarcoma

Danielli, S. G., Wei, Y., Dyer, M. A., Stewart, E. A., Sheppard, H., Wachtel, M., Schäfer, B. W., Patel, A. G., & Langenau, D. M. (2024) · Nature Communications · doi:10.1038/s41467-024-50527-2 · Cited by 49 · see citing works

Human aneuploid cells depend on the RAF/MEK/ERK pathway for overcoming increased DNA damage

Zerbib, J., Ippolito, M. R., Eliezer, Y., Feudis, G. D., Reuveni, E., Kadmon, A. S., Martin, S., Viganò, S., Leor, G., Berstler, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52176-x · Cited by 47 · see citing works

An evolutionary framework for treating pediatric sarcomas

Reed, D. R., Metts, J. L., Pressley, M., Fridley, B. L., Hayashi, M., Isakoff, M. S., Loeb, D. M., Makanji, R. J., Roberts, R. D., Trucco, M. M., et al. (2020) · Cancer · doi:10.1002/cncr.32777 · Cited by 47 · see citing works

Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach

Schott, C. R., Koehne, A. L., Sayles, L. C., Young, E. P., Luck, C., Yu, K., Lee, A. G., Breese, M. R., Leung, S. G., Xu, H., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0873 · Cited by 45 · see citing works

Phenotypic profiling with a living biobank of primary rhabdomyosarcoma unravels disease heterogeneity and AKT sensitivity

Manzella, G., Schreck, L. D., Breunis, W. B., Molenaar, J. J., Merks, J. H. M., Barr, F. G., Sun, W., Römmele, M., Zhang, L., Tchinda, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18388-7 · Cited by 45 · see citing works

Clinical, Genomic, and Pharmacological Study of MYCN-Amplified RB1 Wild-Type Metastatic Retinoblastoma

Zugbi, S., Ganiewich, D., Bhattacharyya, A., Aschero, R., Ottaviani, D., Sampor, C., Cafferata, E. G. A., Mena, M. D., Sgroi, M., Winter, U., et al. (2020) · Cancers · doi:10.3390/cancers12092714 · Cited by 45 · see citing works

CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice

Li, N., Torres, M. B., Spetz, M. R., Wang, R., Peng, L., Tian, M., Dower, C. M., Nguyen, R., Sun, M., Tai, C., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100297 · Cited by 45 · see citing works

Refined high-content imaging-based phenotypic drug screening in zebrafish xenografts

Sturtzel, C., Grissenberger, S., Bozatzi, P., Scheuringer, E., Wenninger-Weinzierl, A., Zajec, Ž., Dernovšek, J., Pascoal, S., Gehl, V., Kutsch, A., et al. (2023) · npj Precision Oncology · doi:10.1038/s41698-023-00386-9 · Cited by 44 · see citing works

The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo

Xu, N., Hua, Z., Ba, G., Zhang, S., Liu, Z., Thiele, C. J., & Li, Z. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1107-1 · Cited by 44 · see citing works

Targeted Therapy–based Combination Treatment in Rhabdomyosarcoma

van Erp, A. E. M., Versleijen‐Jonkers, Y. M. H., van der Graaf, W. T. A., & Fleuren, E. D. G. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1131 · Cited by 43 · see citing works

In vitro and in vivo drug screens of tumor cells identify novel therapies for high‐risk child cancer

Lau, L. M. S., Mayoh, C., Xie, J., Barahona, P., MacKenzie, K. L., Wong, M., Kamili, A., Tsoli, M., Failes, T. W., Kumar, A., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202114608 · Cited by 43 · see citing works

The myokine Fibcd1 is an endogenous determinant of myofiber size and mitigates cancer-induced myofiber atrophy

Graça, F. A., Rai, M., Hunt, L. C., Stephan, A., Wang, Y., Gordon, B., Wang, R., Quarato, G., Xu, B., Fan, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30120-1 · Cited by 41 · see citing works

Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells

Ippolito, M. R., Zerbib, J., Eliezer, Y., Reuveni, E., Viganò, S., Feudis, G. D., Shulman, E. D., Kadmon, A. S., Slutsky, R., Chang, T., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-0309 · Cited by 41 · see citing works

Longitudinal high-resolution imaging through a flexible intravital imaging window

Jacquemin, G., Benavente-Diaz, M., Djaber, S., Bore, A., Dangles‐Marie, V., Surdez, D., Tajbakhsh, S., Fré, S., & Lloyd‐Lewis, B. (2021) · Science Advances · doi:10.1126/sciadv.abg7663 · Cited by 40 · see citing works

Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma

Landuzzi, L., Manara, M. C., Lollini, P.-L., & Scotlandi, K. (2021) · Cells · doi:10.3390/cells10020416 · Cited by 39 · see citing works

Cir-ITCH inhibits gastric cancer migration, invasion and proliferation by regulating the Wnt/β-catenin pathway

Yang, P., & Wang, H. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-74452-8 · Cited by 39 · see citing works

Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma

Odeniyide, P., Yohe, M. E., Pollard, K., Vaseva, A. V., Calizo, A., Zhang, L., Rodríguez, F. J., Gross, J. M., Allen, A. N., Wan, X., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02305-x · Cited by 38 · see citing works

HNRNPH1 is required for rhabdomyosarcoma cell growth and survival

Li, Y., Bakke, J., Finkelstein, D., Zeng, H., Wu, J., & Chen, T. (2018) · Oncogenesis · doi:10.1038/s41389-017-0024-4 · Cited by 38 · see citing works

Histone deacetylase inhibition prevents the growth of primary and metastatic osteosarcoma

McGuire, J., Nerlakanti, N., Lo, C. H., Tauro, M., Utset‐Ward, T. J., Reed, D. R., & Lynch, C. C. (2020) · International Journal of Cancer · doi:10.1002/ijc.33046 · Cited by 38 · see citing works

Simple droplet microfluidics platform for drug screening on cancer spheroids

Parent, C., Kiran Raj, M., Zhou, Y., Aubert, V., Surdez, D., Delattre, O., Wilhelm, C., & Viovy, J. (2023) · Lab on a Chip · doi:10.1039/d3lc00417a · Cited by 37 · see citing works

Predicting Cancer Drug Response In Vivo by Learning an Optimal Feature Selection of Tumour Molecular Profiles

Nguyen, L. C., Naulaerts, S., Bomane, A., Bruna, A., Ghislat, G., & Ballester, P. J. (2021) · Biomedicines · doi:10.3390/biomedicines9101319 · Cited by 36 · see citing works

A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors

Costa, M. E. M. D., Zaïdi, S., Scoazec, J., Droit, R., Lim, W. C., Marchais, A., Salmon, J., Cherkaoui, S., Morscher, R. J., Laurent, A. P., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05320-0 · Cited by 35 · see citing works

Glycine decarboxylase is a transcriptional target of MYCN required for neuroblastoma cell proliferation and tumorigenicity

Alptekin, A., Ye, B., Yu, Y., Poole, C. J., van Riggelen, J., Zha, Y., & Ding, H. (2019) · Oncogene · doi:10.1038/s41388-019-0967-3 · Cited by 35 · see citing works

Immune characterization of pre-clinical murine models of neuroblastoma

Webb, E. R., Lanati, S., Wareham, C., Easton, A., Dunn, S. N., Inzhelevskaya, T., Sadler, F. M., James, S., Ashton‐Key, M., Cragg, M. S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-73695-9 · Cited by 35 · see citing works

Therapeutic targeting of both dihydroorotate dehydrogenase and nucleoside transport in MYCN-amplified neuroblastoma

Yu, Y., Ding, J., Zhu, S., Alptekin, A., Dong, Z., Yan, C., Zha, Y., & Ding, H. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04120-w · Cited by 35 · see citing works

A spatial cell atlas of neuroblastoma reveals developmental, epigenetic and spatial axis of tumor heterogeneityPreprint

Patel, A. G., Ashenberg, O., Collins, N. B., Segerstolpe, Å., Jiang, S., Slyper, M., Huang, X., Caraccio, C., Jin, H., Sheppard, H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.07.574538 · Cited by 35 · see citing works

Enhancement of anti‐sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2‐targeted CAR

Lam, P. Y., Omer, N., Wong, J., Tu, C., Alim, L., Rossi, G. R., Victorova, M., Tompkins, H., Lin, C., Mehdi, A. M., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70140 · Cited by 34 · see citing works

Positron Emission Tomography Detects In Vivo Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma

Butch, E. R., Mead, P. E., Diaz, V. A., Sheppard, H., Stewart, E. A., Mishra, J. K., Kim, J.-E., Bahrami, A., Dearling, J. L. J., Packard, A. B., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3340 · Cited by 34 · see citing works

Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

Tucker, E. R., Jiménez, I., Chen, L., Bellini, A., Gorrini, C., Calton, E. A., Gao, Q., Che, H., Poon, E., Jamin, Y., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-2274 · Cited by 34 · see citing works

Barriers to accessing public cancer genomic data

Learned, K., Durbin, A., Currie, R., Kephart, E. T., Beale, H. C., Sanders, L. M., Pfeil, J., Goldstein, T. C., Salama, S. R., Haussler, D., et al. (2019) · Scientific Data · doi:10.1038/s41597-019-0096-4 · Cited by 34 · see citing works

Recent Advances in Pediatric Cancer Research

McEachron, T. A., & Helman, L. J. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1191 · Cited by 33 · see citing works

Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma

Hansson, K., Radke, K., Aaltonen, K. E., Saarela, J., Mañas, A., Sjölund, J., Smith, E. M. K., Pietras, K., Påhlman, S., Wennerberg, K., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aba4434 · Cited by 33 · see citing works

Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft Models

Gatzweiler, C., Ridinger, J., Herter, S., Gerloff, X. F., ElHarouni, D., Berker, Y., Imle, R., Schmitt, L., Kreth, S., Stainczyk, S. A., et al. (2022) · Cancers · doi:10.3390/cancers14030849 · Cited by 33 · see citing works

Patient-derived xenograft models in musculoskeletal malignancies

Wan, L., Chao, T., Chen, R., Su, J., & Li, Z. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1487-6 · Cited by 32 · see citing works

Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression

Shaw, T. I., Wagner, J., Tian, L., Wickman, E., Poudel, S., Wang, J., Paul, R., Koo, S. C., Lu, M., Sheppard, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47649-y · Cited by 31 · see citing works

Patient-derived xenograft models in hepatopancreatobiliary cancer

Pan, B., Wei, X., & Xu, X. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02454-9 · Cited by 31 · see citing works

Structurally Complex Osteosarcoma Genomes Exhibit Limited Heterogeneity within Individual Tumors and across Evolutionary Time

Rajan, S., Zaccaria, S., Cannon, M. V., Cam, M., Gross, A. C., Raphael, B. J., & Roberts, R. D. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0348 · Cited by 31 · see citing works

Deciphering intratumoral heterogeneity using integrated clonal tracking and single-cell transcriptome analyses

Contreras-Trujillo, H., Eerdeng, J., Akre, S., Du, J., Contreras, J., Gala, B., Vergel-Rodriguez, M., Lee, Y., Jorapur, A., Andreasian, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26771-1 · Cited by 30 · see citing works

Genomic Complexity of Osteosarcoma and Its Implication for Preclinical and Clinical Targeted Therapies

Schott, C. R., Shah, A. T., & Sweet-Cordero, A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43085-6_1 · Cited by 30 · see citing works

An integrated single-cell RNA-seq map of human neuroblastoma tumors and preclinical models uncovers divergent mesenchymal-like gene expression programs

Chapple, R. H., Liu, X., Natarajan, S., Alexander, M. I. M., Kim, Y., Patel, A. G., LaFlamme, C. W., Pan, M., Wright, W. C., Lee, H.-M., et al. (2024) · Genome biology · doi:10.1186/s13059-024-03309-4 · Cited by 29 · see citing works

Progress in building clinically relevant patient‐derived tumor xenograft models for cancer research

Wang, W., Li, Y., Lin, K., Wang, X., Tu, Y., & Zhuo, Z. (2023) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12349 · Cited by 29 · see citing works

IL-18R supported CAR T cells targeting oncofetal tenascin C for the immunotherapy of pediatric sarcoma and brain tumors

Wickman, E., Lange, S., Wagner, J., Ibañez-Vega, J., Tian, L., Lu, M., Sheppard, H., Chiang, J., Koo, S. C., Vogel, P., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009743 · Cited by 27 · see citing works

Establishment and evaluation of four different types of patient-derived xenograft models

Ji, X., Chen, S., Guo, Y., Li, W., Qi, X., Yang, H., Xiao, S., Fang, G., Hu, J., Wen, C., et al. (2017) · Cancer Cell International · doi:10.1186/s12935-017-0497-4 · Cited by 27 · see citing works

The translational repressor 4E-BP1 regulates RRM2 levels and functions as a tumor suppressor in Ewing sarcoma tumors

Goss, K. L., Koppenhafer, S. L., Waters, T. W., Terry, W. W., Wen, K., Wu, M., Ostergaard, J., Gordon, P. M., & Gordon, D. J. (2020) · Oncogene · doi:10.1038/s41388-020-01552-0 · Cited by 27 · see citing works

Prognostic value of patient‐derived xenograft engraftment in pediatric sarcomas

Castillo‐Ecija, H., Pascual‐Pasto, G., Pérez‐Jaume, S., Resa‐Pares, C., Vilà-Ubach, M., Monterrubio, C., Jimenez‐Cabaco, A., Baulenas‐Farres, M., Muñoz‐Aznar, O., Salvador, N., et al. (2021) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.210 · Cited by 27 · see citing works

Cancer metastasis chemoprevention prevents circulating tumour cells from germination

Xie, X., Li, Y., Lian, S., Lu, Y., & Jia, L. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01174-w · Cited by 27 · see citing works

The next best thing

Murakami, M. A., & Weinstock, D. M. (2017) · Nature · doi:10.1038/nature23545 · Cited by 7 · see citing works

Preclinical Pediatric Molecular Analysis for Therapy Choice (MATCH)Preprint

Blankenship, K., Chang, T., Fan, Y., Gordon, B., Wright, W. C., Kieffer, M., Karlström, Å., Jeon, J., Patel, A. G., Dapper, J. D., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.22.604648 · Cited by 1 · see citing works

Treatment responses profiling and molecular characterization of patient-derived pediatric soft tissue and bone tumor preclinical models

Bardinet, V. (2024) · doi:10.17169/refubium-44692

Molecular analysis of solid tumors (MAST): A protocol for comprehensive preclinical evaluation of pediatric solid tumors.

Federico, S. M., Stewart, E. A., Bradley, C. L., McEvoy, J. D., Loh, A. H. P., Shelat, A. A., Zhang, J., Chen, X. '., Pappo, A. S., & Dyer, M. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.10036

Abstract 6149: An innovative integrated cloud-based data portal for orthotopic patient-derived xenografts (O-PDX) available through the Childhood Solid Tumor Network (CSTN)

Karlström, Å., Chang, T., Gentry, D., Zhou, X., Stewart, E. A., Gordon, B., Federico, S. M., Brennan, R. C., Clay, M. R., Frase, S., et al. (2020) · Cancer Research · doi:10.1158/1538-7445.am2020-6149